Atomistry » Calcium » PDB 1cxk-1dds » 1d8f
Atomistry »
  Calcium »
    PDB 1cxk-1dds »
      1d8f »

Calcium in PDB 1d8f: Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.

Enzymatic activity of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.

All present enzymatic activity of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.:
3.4.24.17;

Protein crystallography data

The structure of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor., PDB code: 1d8f was solved by M.Y.Cheng, B.De, S.Pikul, N.G.Almstead, M.G.Natchus, M.V.Anastasio, S.J.Mcphail, C.E.Snider, Y.O.Taiwo, L.Y.Chen, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 8.00 / 2.40
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 38.270, 78.540, 106.580, 90.00, 90.00, 90.00
R / Rfree (%) 29.4 / 25.2

Other elements in 1d8f:

The structure of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. also contains other interesting chemical elements:

Zinc (Zn) 4 atoms

Calcium Binding Sites:

The binding sites of Calcium atom in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. (pdb code 1d8f). This binding sites where shown within 5.0 Angstroms radius around Calcium atom.
In total 6 binding sites of Calcium where determined in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor., PDB code: 1d8f:
Jump to Calcium binding site number: 1; 2; 3; 4; 5; 6;

Calcium binding site 1 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 1 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 1 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca303

b:2.0
occ:1.00
O A:VAL163 2.3 3.6 1.0
O A:GLY159 2.3 8.7 1.0
OD2 A:ASP181 2.4 2.0 1.0
OE2 A:GLU184 2.4 2.0 1.0
O A:GLY161 2.4 5.5 1.0
OD1 A:ASP158 2.5 4.9 1.0
C A:VAL163 3.5 2.8 1.0
CG A:ASP181 3.5 2.0 1.0
C A:GLY159 3.5 5.7 1.0
C A:GLY161 3.6 4.6 1.0
CD A:GLU184 3.6 2.0 1.0
CG A:ASP158 3.8 6.5 1.0
N A:GLY161 3.9 2.0 1.0
C A:PRO160 4.0 5.0 1.0
N A:VAL163 4.0 2.0 1.0
CB A:ASP181 4.1 2.0 1.0
N A:GLY159 4.2 5.1 1.0
C A:ASP158 4.2 6.7 1.0
CA A:VAL163 4.3 2.0 1.0
CA A:GLY161 4.3 2.0 1.0
OE1 A:GLU184 4.3 8.3 1.0
N A:ASP158 4.3 4.6 1.0
O A:PRO160 4.3 4.4 1.0
N A:PRO160 4.4 5.8 1.0
N A:LEU164 4.4 3.3 1.0
C A:ASN162 4.4 5.3 1.0
CA A:PRO160 4.4 2.0 1.0
CA A:GLY159 4.5 2.2 1.0
O A:ASP158 4.5 8.8 1.0
OD2 A:ASP158 4.5 14.6 1.0
CG A:GLU184 4.5 4.0 1.0
OD1 A:ASP181 4.6 3.0 1.0
CA A:ASP158 4.6 5.3 1.0
N A:ASN162 4.6 5.6 1.0
CB A:VAL163 4.6 2.9 1.0
CA A:LEU164 4.6 2.0 1.0
CB A:ASP158 4.8 8.4 1.0
CA A:ASN162 4.9 5.9 1.0
CB A:ASN162 5.0 2.6 1.0

Calcium binding site 2 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 2 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 2 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca304

b:5.5
occ:1.00
O A:ASP182 2.3 12.6 1.0
OD1 A:ASP107 2.3 9.7 1.0
O A:GLU184 2.5 2.0 1.0
OD2 A:ASP107 2.6 14.1 1.0
OD1 A:ASP182 2.8 2.0 1.0
CG A:ASP107 2.9 2.0 1.0
C A:ASP182 3.3 5.8 1.0
O A:HOH22 3.4 17.6 1.0
C A:GLU184 3.6 2.0 1.0
CG A:ASP182 3.7 13.6 1.0
CA A:ASP182 3.9 4.2 1.0
N A:GLU184 4.1 3.9 1.0
CA A:GLN185 4.3 2.1 1.0
OG1 A:THR105 4.3 2.0 1.0
N A:ASP183 4.3 6.5 1.0
CB A:ASP182 4.3 9.0 1.0
CB A:ASP107 4.3 2.0 1.0
N A:GLN185 4.4 2.0 1.0
OE1 A:GLN185 4.4 2.0 1.0
C A:ASP183 4.5 6.8 1.0
CD1 A:TRP186 4.6 2.0 1.0
CA A:ASP183 4.6 5.0 1.0
CA A:GLU184 4.6 3.4 1.0
OD2 A:ASP182 4.6 17.6 1.0
N A:TRP186 4.7 4.4 1.0
CG A:PRO106 4.9 2.0 1.0

Calcium binding site 3 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 3 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 3 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Ca305

b:2.0
occ:1.00
O A:ASN175 2.4 2.2 1.0
O A:ASP141 2.4 7.2 1.0
O A:GLY173 2.5 2.0 1.0
OD1 A:ASP177 2.6 3.8 1.0
O A:HOH5 3.1 22.2 1.0
C A:ASP141 3.5 6.5 1.0
C A:ASN175 3.6 2.0 1.0
CG A:ASP177 3.6 2.0 1.0
C A:GLY173 3.7 5.2 1.0
O A:ALA140 3.9 9.0 1.0
OD2 A:ASP177 4.0 2.0 1.0
CA A:ASP141 4.1 7.2 1.0
N A:ASP177 4.2 2.6 1.0
N A:ASN175 4.3 5.7 1.0
N A:GLY173 4.3 7.3 1.0
O A:GLY171 4.4 2.0 1.0
C A:ILE174 4.4 5.6 1.0
CA A:GLY176 4.4 3.1 1.0
N A:GLY176 4.4 2.0 1.0
C A:GLY176 4.4 2.0 1.0
CA A:GLY173 4.5 7.9 1.0
CA A:ASN175 4.5 2.2 1.0
N A:ILE142 4.5 2.0 1.0
O A:ILE174 4.6 8.1 1.0
OE2 A:GLU139 4.6 33.0 1.0
N A:ILE174 4.7 6.1 1.0
CH2 A:TRP92 4.7 2.0 1.0
C A:PRO172 4.7 7.7 1.0
CB A:ASP177 4.8 2.0 1.0
CA A:ILE174 4.8 7.3 1.0
CA A:ILE142 4.8 4.0 1.0
CG A:MET143 4.9 2.0 1.0
C A:ALA140 4.9 8.0 1.0
CA A:ASP177 4.9 2.5 1.0
N A:MET143 4.9 6.2 1.0

Calcium binding site 4 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 4 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 4 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Ca803

b:2.0
occ:1.00
OE2 B:GLU684 2.3 2.0 1.0
OD1 B:ASP658 2.3 2.0 1.0
OD2 B:ASP681 2.3 2.0 1.0
O B:VAL663 2.4 10.5 1.0
O B:GLY659 2.4 7.9 1.0
O B:GLY661 2.6 8.0 1.0
CG B:ASP681 3.4 3.4 1.0
C B:VAL663 3.5 4.9 1.0
CG B:ASP658 3.5 2.0 1.0
CD B:GLU684 3.5 6.4 1.0
C B:GLY659 3.6 10.4 1.0
C B:GLY661 3.7 2.0 1.0
CB B:ASP681 4.1 3.7 1.0
N B:VAL663 4.1 2.0 1.0
OD2 B:ASP658 4.1 2.0 1.0
C B:ASP658 4.2 11.3 1.0
N B:GLY661 4.2 2.6 1.0
O B:ASP658 4.2 11.6 1.0
CA B:VAL663 4.3 2.0 1.0
OE1 B:GLU684 4.3 9.3 1.0
C B:ASN662 4.3 2.0 1.0
N B:GLY659 4.4 11.4 1.0
OD1 B:ASP681 4.4 2.2 1.0
CG B:GLU684 4.4 2.0 1.0
N B:LEU664 4.4 5.1 1.0
C B:PRO660 4.5 5.5 1.0
CA B:PRO660 4.5 9.5 1.0
CA B:GLY659 4.5 13.6 1.0
N B:PRO660 4.5 8.3 1.0
CA B:GLY661 4.5 2.0 1.0
CA B:LEU664 4.6 2.0 1.0
CB B:ASP658 4.6 6.7 1.0
N B:ASP658 4.6 8.3 1.0
N B:ASN662 4.7 5.1 1.0
CA B:ASP658 4.7 8.3 1.0
O B:ASN662 4.8 2.0 1.0
CB B:VAL663 4.8 2.0 1.0
CA B:ASN662 4.9 3.6 1.0

Calcium binding site 5 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 5 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 5 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Ca804

b:12.9
occ:1.00
OD2 B:ASP607 2.4 2.0 1.0
O B:ASP682 2.4 4.7 1.0
OD1 B:ASP607 2.4 4.0 1.0
OD1 B:ASP682 2.6 2.0 1.0
O B:GLU684 2.7 2.0 1.0
CG B:ASP607 2.7 2.0 1.0
C B:ASP682 3.4 2.4 1.0
CG B:ASP682 3.6 2.0 1.0
C B:GLU684 3.9 5.5 1.0
CA B:ASP682 3.9 2.0 1.0
OG1 B:THR605 4.0 8.5 1.0
CB B:ASP682 4.2 6.3 1.0
CB B:ASP607 4.3 2.7 1.0
CD1 B:TRP686 4.3 2.2 1.0
N B:GLU684 4.4 3.4 1.0
OD2 B:ASP682 4.4 6.1 1.0
N B:ASP683 4.5 5.8 1.0
CA B:GLN685 4.6 5.5 1.0
O B:HOH11 4.7 13.1 1.0
N B:GLN685 4.7 9.7 1.0
CD B:PRO606 4.7 2.0 1.0
C B:ASP683 4.8 2.0 1.0
CA B:GLU684 4.8 3.9 1.0
NE1 B:TRP686 4.9 2.0 1.0
N B:TRP686 4.9 6.8 1.0
CA B:ASP683 4.9 3.5 1.0
N B:ASP607 4.9 2.4 1.0

Calcium binding site 6 out of 6 in 1d8f

Go back to Calcium Binding Sites List in 1d8f
Calcium binding site 6 out of 6 in the Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor.


Mono view


Stereo pair view

A full contact list of Calcium with other atoms in the Ca binding site number 6 of Crystal Structure of MMP3 Complexed with A Piperazine Based Inhibitor. within 5.0Å range:
probe atom residue distance (Å) B Occ
B:Ca805

b:6.5
occ:1.00
O B:GLY673 2.4 9.0 1.0
OD1 B:ASP677 2.4 2.0 1.0
O B:HOH10 2.4 17.4 1.0
O B:ASP641 2.4 2.0 1.0
O B:ASN675 2.5 8.7 1.0
CG B:ASP677 3.4 8.5 1.0
C B:ASP641 3.6 2.0 1.0
C B:GLY673 3.6 6.3 1.0
C B:ASN675 3.6 4.9 1.0
OD2 B:ASP677 3.9 13.9 1.0
O B:ALA640 4.0 4.6 1.0
C B:ILE674 4.1 5.0 1.0
N B:ASP677 4.1 2.0 1.0
N B:ASN675 4.1 2.0 1.0
O B:ILE674 4.2 10.4 1.0
CA B:ASP641 4.3 2.0 1.0
CA B:ILE674 4.4 7.0 1.0
C B:GLY676 4.4 2.0 1.0
N B:ILE674 4.4 7.2 1.0
CA B:GLY676 4.5 2.0 1.0
N B:GLY676 4.5 3.6 1.0
N B:GLY673 4.5 2.0 1.0
O B:GLY671 4.5 2.0 1.0
CA B:ASN675 4.5 2.0 1.0
CA B:GLY673 4.5 3.5 1.0
O B:HOH30 4.6 17.3 1.0
N B:ILE642 4.6 2.0 1.0
CB B:ASP677 4.6 5.0 1.0
N B:MET643 4.6 4.2 1.0
CG B:MET643 4.7 2.0 1.0
C B:PRO672 4.7 2.0 1.0
CA B:ASP677 4.7 2.0 1.0
CA B:ILE642 4.8 2.0 1.0
O B:HOH2 4.9 4.1 1.0
O B:PRO672 4.9 4.7 1.0
C B:ALA640 5.0 4.4 1.0

Reference:

M.Cheng, B.De, S.Pikul, N.G.Almstead, M.G.Natchus, M.V.Anastasio, S.J.Mcphail, C.E.Snider, Y.O.Taiwo, L.Chen, C.M.Dunaway, F.Gu, M.E.Dowty, G.E.Mieling, M.J.Janusz, S.Wang-Weigand. Design and Synthesis of Piperazine-Based Matrix Metalloproteinase Inhibitors. J.Med.Chem. V. 43 369 2000.
ISSN: ISSN 0022-2623
PubMed: 10669564
DOI: 10.1021/JM990366Q
Page generated: Thu Jul 11 07:26:45 2024

Last articles

Zn in 9JPJ
Zn in 9JP7
Zn in 9JPK
Zn in 9JPL
Zn in 9GN6
Zn in 9GN7
Zn in 9GKU
Zn in 9GKW
Zn in 9GKX
Zn in 9GL0
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy